After many months of planning and anticipation, DIA 2022 in Chicago finally arrived. For the first time in over 2 years, colleagues, partners, and friends gathered at the Drug Information Association conference in person. And then, seemingly in the blink of an eye, the conference was over! Here are some key takeaways from ClinChoice: Technology: … Continued
Clinical research is a rapidly evolving field. As technologies improve and advanced capabilities become accessible, new tools, methodologies, and processes also emerge. Depending on the area of research, size, target demographics, and other factors, these new technologies can help improve efficiency, accuracy, speed, and the quality of data gathered and analyzed. A key element of … Continued
How rare are rare diseases? The Orphan Drug Act defines a rare disease as a disease or condition that affects less than 200,000 people in the United States.
We have a diverse client base who develop lifechanging medical devices, vaccines, and other products. Our enriching work environment offers programmers exposure to a wide range of clients, scientific areas, geographic settings, and a highly talented, multicultural team. Watch now to learn more about our industry-leading team, exceptional leadership, remote or hybrid work model, and … Continued
With the backing of exciting new investors, ClinChoice is charting a new course that combines our expertise and ambition to aid the continuous development and monitoring of new drugs, devices, and vaccines. Listen to Mahesh Mudnur – President, Asia-Pacific, and Sridhar Punniamurthi – Director, Statistical Programming, as they share their vision for the Biometrics group in 2022.
This past week, ClinChoice participated in the Outsourcing Clinical Trials conference in Boston as a Sponsor.
People have always been the cornerstone of success at ClinChoice. Led by strong leadership that gives a depth of experience and direction to advancements, we prepare the next generation of leaders to take on new challenges with skill and integrity. Mahesh Mudnur – President, Asia-Pacific, elaborates on how ClinChoice has been successful for the last 26 years. … Continued
For over 26 years, ClinChoice has been proudly providing deep insights that help leading medical device and life sciences manufacturers bring lifechanging products to market. Mahesh Mudnur, President – Asia-Pacific, and Sridhar Punniamurthi, Director – Statistical Programming, expand on how we focus on our client’s needs and deliver projects on time with quality. Watch now to learn … Continued
In this brief video, Mahesh Mudnur, President – Asia-Pacific, delves into ClinChoice’s past and present. With centers in China, the US, Philippines, and Japan, and over 2200 professionals worldwide, our agility compliments our culture of client service and success. Watch now to learn about our commitment to reliable partnerships and providing deep domain experience in … Continued
Technological advancements in manufacturing make it possible for manufacturers to commercially produce personalized custom medical devices (CMD) much faster. The advancements, when coupled with regulatory changes, can be confusing. That’s why we’ve created this brief review to help clarify the most critical points within recent European Medical Device Regulation (MDR) updates. MDR Article 2(3) defines … Continued
